{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:04:29Z","timestamp":1763982269697,"version":"3.45.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Finger-stick glucose monitoring is commonly used in the clinical management of diabetes as a tool to obtain a reliable estimate of venous glucose levels. However, it should be noted that discrepancies can arise in certain situations between the finger-stick glucose value and venous blood glucose concentration. We present herein the case of a 76-year-old woman with dermatomyositis presenting with artifactual hypoglycemia, in which finger-stick glucose monitoring exhibited false-low values due to Raynaud\u2019s phenomenon. Despite the low glucose level (&amp;lt;54 mg\/dL) on finger-stick glucose monitoring, she was asymptomatic, and occasional laboratory blood tests failed to detect apparent hypoglycemia. We suspected artifactual hypoglycemia to be caused by Raynaud\u2019s phenomenon, and consistently, switching the blood sampling site from the finger to the earlobe ameliorated the discrepancy against the actual venous glucose levels. Given the prevalence of steroid-induced diabetes in patients with Raynaud\u2019s phenomenon, clinicians should be aware that finger-stick glucose monitoring can present false-low values due to Raynaud\u2019s phenomenon, thus avoiding unnecessary investigations searching for the cause of \u201chypoglycemia,\u201d or conversely, preventing underestimation of the actual hyperglycemia.<\/jats:p>","DOI":"10.3389\/fendo.2025.1695633","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:01:12Z","timestamp":1763982072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artifactual hypoglycemia caused by Raynaud\u2019s phenomenon: A case report with literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Hidenori","family":"Nishioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamotoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Itoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Kosuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujiko","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S006","article-title":"6. Glycemic goals and hypoglycemia: Standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular\u00a0disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119357","article-title":"Effects of hypoglycemia on cardiovascular function in patients with diabetes","volume":"24","author":"Christou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B5","unstructured":"ISO 15197:2013, in vitro diagnostic test systems \u2014 requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus\n          \n          \n          International Organization for Standardization\n          \n          2013"},{"key":"B6","doi-asserted-by":"publisher","first-page":"110911","DOI":"10.1016\/j.clinbiochem.2025.110911","article-title":"Assessment of accuracy, clinical validity, and analytical linearity in point-of-care glucose monitoring devices for diabetes mellitus: A systematic review and meta-analysis","volume":"137","author":"Ukpe","year":"2025","journal-title":"Clin Biochem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/heartjnl-2017-311579","article-title":"Acute stress-induced (takotsubo) cardiomyopathy","volume":"104","author":"Dawson","year":"2018","journal-title":"Heart"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2891","article-title":"Artifactual hypoglycemia: an old term for a new classification","volume":"37","author":"Tarasova","year":"2014","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13572","article-title":"Failure of glucose monitoring in an individual with pseudohypoglycemia","volume":"63","author":"Lee","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4158\/EP.ep.14.3.337","article-title":"Pseudohypoglycemia: a cause for unreliable finger-stick glucose measurements","volume":"14","author":"El Khoury","year":"2008","journal-title":"Endocr Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.12.2157","article-title":"Case of pseudohypoglycemia","volume":"24","author":"Rushakoff","year":"2001","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000164","article-title":"Perioperative glucose management: Point-of-care testing and pseudohypoglycemia","volume":"5","author":"Radosevich","year":"2015","journal-title":"A A Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud\u2019s phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/003693309904400102","article-title":"Vascular abnormalities in Raynaud\u2019s phenomenon","volume":"44","author":"Khan","year":"1999","journal-title":"Scott Med J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1976.41.4.565","article-title":"Effects of arterial versus venous sampling on analysis of glucose kinetics in man","volume":"41","author":"McGuire","year":"1976","journal-title":"J Appl Physiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/cd24-0077","article-title":"Artifactual hypoglycemia caused by raynaud\u2019s phenomenon in a person with diabetes","volume":"43","author":"Sherman","year":"2025","journal-title":"Clin Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e41900","DOI":"10.7759\/cureus.41900","article-title":"New and delayed artifactual hypoglycemia following septic shock in two Scleroderma patients","volume":"15","author":"Guzner","year":"2023","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.951377","article-title":"Case report: Artifactual hypoglycemia: A condition that should not be forgotten","volume":"13","author":"Amaral","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2020.1837575","article-title":"Artifactual hypoglycemia in a patient with systemic sclerosis","volume":"77","author":"Mertens","year":"2022","journal-title":"Acta Clin Belg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"13202","DOI":"10.7196\/SAMJ.2021.v111i2.15451","article-title":"Artifactual hypoglycaemia in a patient with scleroderma and Raynaud\u2019s phenomenon","volume":"111","author":"Osman","year":"2021","journal-title":"S Afr Med J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez118","article-title":"Clinical impact of artifactual hypoglycaemia and its diagnosis at the bedside","volume":"58","author":"Drenthen","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2017.03.003","article-title":"Importance of\u00a0alternative-site blood glucose testing in the diagnosis of artifactual hypoglycaemia in\u00a0systemic scleroderma","volume":"43","author":"Dubourdieu","year":"2017","journal-title":"Diabetes Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7390927","DOI":"10.1155\/2016\/7390927","article-title":"Artifactual hypoglycaemia in systemic sclerosis and Raynaud\u2019s phenomenon: A clinical case report and short review","volume":"2016","author":"Bishay","year":"2016","journal-title":"Case Rep Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-12-1020","article-title":"Fingerstick glucose determination in shock","volume":"114","author":"Atkin","year":"1991","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.3390\/ijms26073218","article-title":"Cardiovascular biomarkers: Tools for precision diagnosis and prognosis","volume":"26","author":"Netala","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 years from discovery to therapy: 30 years from discovery to therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64531-X","article-title":"Endothelin-1 in heart failure: a new therapeutic target","volume":"348","author":"Kaddoura","year":"1996","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e21681","DOI":"10.7759\/cureus.21681","article-title":"Raynaud\u2019s phenomenon: Reviewing the pathophysiology and management strategies","volume":"14","author":"Nawaz","year":"2022","journal-title":"Cureus"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5758\/vsi.240047","article-title":"Raynaud\u2019s phenomenon: A current update on pathogenesis, diagnostic workup, and treatment","volume":"40","author":"Ture","year":"2024","journal-title":"Vasc Special Int"},{"key":"B31","article-title":"Reversible cardiogenic shock in an angry woman\u2013case report and review of the literature","volume":"12","author":"Kovacs","year":"1996","journal-title":"Can J Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0211-8","article-title":"Acute myocardial infarction in systemic sclerosis patients: a case series","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(78)90297-1","article-title":"Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis","volume":"95","author":"Bulkley","year":"1978","journal-title":"Am Heart J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.01.269","article-title":"Prevalence of migraine and Raynaud phenomenon in women with apical ballooning syndrome (Takotsubo or stress cardiomyopathy)","volume":"111","author":"Scantlebury","year":"2013","journal-title":"Am J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of takotsubo syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud\u2019s phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: A joint position statement of the American diabetes association and the European association for the study of diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00000446-200508000-00028","article-title":"Raynaud phenomenon: Whether it\u2019s primary or secondary, there is no cure, but treatment can alleviate symptoms","volume":"105","author":"Reilly","year":"2005","journal-title":"Am J Nurs"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:01:17Z","timestamp":1763982077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":39,"alternative-id":["10.3389\/fendo.2025.1695633"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1695633","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"article-number":"1695633"}}